2024/04/08 更新

写真a

サワダ リュウスケ
澤田 隆介
SAWADA Ryusuke
所属
医歯薬学域 助教
職名
助教

学位

  • 博士(工学) ( 2009年3月   名古屋大学 )

学歴

  • 名古屋大学   Graduate School of Engineering  

    2006年4月 - 2009年3月

      詳細を見る

  • 名古屋大学   Graduate School of Engineering  

    2004年4月 - 2006年3月

      詳細を見る

経歴

  • 岡山大学   学術研究院医歯薬学域   助教

    2022年7月 - 現在

      詳細を見る

  • 九州工業大学   大学院情報工学研究院   研究職員

    2018年10月 - 2022年6月

      詳細を見る

  • 九州大学   生体防御医学研究所   学術研究員

    2013年10月 - 2015年9月

      詳細を見る

  • University of Georgia   Department of Epidemiology and Biostatistics   Postdoctoral Research Associate

    2011年10月 - 2013年9月

      詳細を見る

  • 名古屋大学   大学院工学研究科   技術補佐員

    2011年4月 - 2011年9月

      詳細を見る

  • 公益財団法人豊田理化学研究所   奨励研究員

    2009年4月 - 2011年3月

      詳細を見る

▼全件表示

 

論文

  • Design and structural optimization of thiadiazole derivatives with potent GLS1 inhibitory activity. 国際誌

    Takuya Okada, Kaho Yamabe, Michiko Jo, Yuko Sakajiri, Tomokazu Shibata, Ryusuke Sawada, Yoshihiro Yamanishi, Daisuke Kanayama, Hisashi Mori, Mineyuki Mizuguchi, Takayuki Obita, Yuko Nabeshima, Keiichi Koizumi, Naoki Toyooka

    Bioorganic & medicinal chemistry letters   93   129438 - 129438   2023年9月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    GLS1 is an attractive target not only as anticancer agents but also as candidates for various potential pharmaceutical applications such as anti-aging and anti-obesity treatments. We performed docking simulations based on the complex crystal structure of GLS1 and its inhibitor CB-839 and found that compound A bearing a thiadiazole skeleton exhibits GLS1 inhibition. Furthermore, we synthesized 27 thiadiazole derivatives in an effort to obtain a more potent GLS1 inhibitor. Among the synthesized derivatives, 4d showed more potent GLS1 inhibitory activity (IC50 of 46.7 µM) than known GLS1 inhibitor DON and A. Therefore, 4d is a very promising novel GLS1 inhibitor.

    DOI: 10.1016/j.bmcl.2023.129438

    PubMed

    researchmap

  • A trial of topiramate for patients with hereditary spinocerebellar ataxia. 国際誌

    Shiroh Miura, Ryusuke Sawada, Akiko Yorita, Hiroshi Kida, Takashi Kamada, Yoshihiro Yamanishi

    Clinical case reports   11 ( 2 )   e6980   2023年2月

     詳細を見る

    記述言語:英語  

    In an open pilot trial, six patients with various hereditary forms of spinocerebellar ataxia (SCA) were assigned to topiramate (50 mg/day) for 24 weeks. Four patients completed the protocol without adverse events. Of these four patients, topiramate was effective for three patients. Some patients with SCA could respond to treatment with topiramate.

    DOI: 10.1002/ccr3.6980

    PubMed

    researchmap

  • Differential effects of proton pump inhibitors and vonoprazan on vascular endothelial growth factor expression in cancer cells. 国際誌

    Rie Ando-Matsuoka, Kenta Yagi, Mayu Takaoka, Yuko Sakajiri, Tomokazu Shibata, Ryusuke Sawada, Akinori Maruo, Koji Miyata, Fuka Aizawa, Hirofumi Hamano, Takahiro Niimura, Yuki Izawa-Ishizawa, Mitsuhiro Goda, Satoshi Sakaguchi, Yoshito Zamami, Yoshihiro Yamanishi, Keisuke Ishizawa

    Drug development research   84 ( 1 )   75 - 83   2022年12月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Proton pump inhibitors (PPIs) are potent inhibitors of gastric acid secretion, used as first-line agents in treating peptic ulcers. However, we have previously reported that PPIs may diminish the therapeutic effect of anti-vascular endothelial growth factor (VEGF) drugs in patients with cancer. In this study, we explored the effects of vonoprazan, a novel gastric acid secretion inhibitor used for the treatment of peptic ulcers, on the secretion of VEGF in cancer cells and attempted to propose it as an alternative PPI for cancer chemotherapy. The effects of PPI and vonoprazan on VEGF expression in cancer cells were compared by real-time reverse transcription-polymerase chain reaction and ELISA. The interaction of vonoprazan and PPIs with transcriptional regulators by docking simulation analysis. In various cancer cell lines, including the human colorectal cancer cell line (LS174T), PPI increased VEGF messenger RNA expression and VEGF protein secretion, while this effect was not observed with vonoprazan. Molecular docking simulation analysis showed that vonoprazan had a lower binding affinity for estrogen receptor alpha (ER-α), one of the transcriptional regulators of VEGF, compared to PPI. Although the PPI-induced increase in VEGF expression was counteracted by pharmacological ER-α inhibition, the effect of vonoprazan on VEGF expression was unchanged. Vonoprazan does not affect VEGF expression in cancer cells, which suggests that vonoprazan might be an alternative to PPIs, with no interference with the therapeutic effects of anti-VEGF cancer chemotherapy.

    DOI: 10.1002/ddr.22013

    PubMed

    researchmap

  • Prediction of the Health Effects of Food Peptides and Elucidation of the Mode-of-action Using Multi-task Graph Convolutional Neural Network. 国際誌

    Itsuki Fukunaga, Ryusuke Sawada, Tomokazu Shibata, Kazuma Kaitoh, Yukie Sakai, Yoshihiro Yamanishi

    Molecular informatics   39 ( 1-2 )   e1900134   2020年1月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Food proteins work not only as nutrients but also modulators for the physiological functions of the human body. The physiological functions of food proteins are basically regulated by peptides encrypted in food protein sequences (food peptides). In this study, we propose a novel deep learning-based method to predict the health effects of food peptides and elucidate the mode-of-action. In the algorithm, we estimate potential target proteins of food peptides using a multi-task graph convolutional neural network, and predict its health effects using information about therapeutic targets for diseases. We constructed predictive models based on 21,103 peptide-protein interactions involving 10,950 peptides and 2,533 proteins, and applied the models to food peptides (e. g., lactotripeptide, isoleucyltyrosine and sardine peptide) defined in food for specified health use. The models suggested potential effects such as blood-pressure lowering effects, blood glucose level lowering effects, and anti-cancer effects for several food peptides. The interactions of food peptides with target proteins were confirmed by docking simulations.

    DOI: 10.1002/minf.201900134

    PubMed

    researchmap

  • In silico systems for predicting chemical-induced side effects using known and potential chemical protein interactions, enabling mechanism estimation.

    Yuto Amano, Hiroshi Honda, Ryusuke Sawada, Yuko Nukada, Masayuki Yamane, Naohiro Ikeda, Osamu Morita, Yoshihiro Yamanishi

    The Journal of toxicological sciences   45 ( 3 )   137 - 149   2020年

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    In silico models for predicting chemical-induced side effects have become increasingly important for the development of pharmaceuticals and functional food products. However, existing predictive models have difficulty in estimating the mechanisms of side effects in terms of molecular targets or they do not cover the wide range of pharmacological targets. In the present study, we constructed novel in silico models to predict chemical-induced side effects and estimate the underlying mechanisms with high general versatility by integrating the comprehensive prediction of potential chemical-protein interactions (CPIs) with machine learning. First, the potential CPIs were comprehensively estimated by chemometrics based on the known CPI data (1,179,848 interactions involving 3,905 proteins and 824,143 chemicals). Second, the predictive models for 61 side effects in the cardiovascular system (CVS), gastrointestinal system (GIS), and central nervous system (CNS) were constructed by sparsity-induced classifiers based on the known and potential CPI data. The cross validation experiments showed that the proposed CPI-based models had a higher or comparable performance than the traditional chemical structure-based models. Moreover, our enrichment analysis indicated that the highly weighted proteins derived from predictive models could be involved in the corresponding functions of the side effects. For example, in CVS, the carcinogenesis-related pathways (e.g., prostate cancer, PI3K-Akt signal pathway), which were recently reported to be involved in cardiovascular side effects, were enriched. Therefore, our predictive models are biologically valid and would be useful for predicting side effects and novel potential underlying mechanisms of chemical-induced side effects.

    DOI: 10.2131/jts.45.137

    PubMed

    researchmap

  • Predicting drug-induced transcriptome responses of a wide range of human cell lines by a novel tensor-train decomposition algorithm. 国際誌

    Michio Iwata, Longhao Yuan, Qibin Zhao, Yasuo Tabei, Francois Berenger, Ryusuke Sawada, Sayaka Akiyoshi, Momoko Hamano, Yoshihiro Yamanishi

    Bioinformatics (Oxford, England)   35 ( 14 )   i191-i199   2019年7月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    MOTIVATION: Genome-wide identification of the transcriptomic responses of human cell lines to drug treatments is a challenging issue in medical and pharmaceutical research. However, drug-induced gene expression profiles are largely unknown and unobserved for all combinations of drugs and human cell lines, which is a serious obstacle in practical applications. RESULTS: Here, we developed a novel computational method to predict unknown parts of drug-induced gene expression profiles for various human cell lines and predict new drug therapeutic indications for a wide range of diseases. We proposed a tensor-train weighted optimization (TT-WOPT) algorithm to predict the potential values for unknown parts in tensor-structured gene expression data. Our results revealed that the proposed TT-WOPT algorithm can accurately reconstruct drug-induced gene expression data for a range of human cell lines in the Library of Integrated Network-based Cellular Signatures. The results also revealed that in comparison with the use of original gene expression profiles, the use of imputed gene expression profiles improved the accuracy of drug repositioning. We also performed a comprehensive prediction of drug indications for diseases with gene expression profiles, which suggested many potential drug indications that were not predicted by previous approaches. SUPPLEMENTARY INFORMATION: Supplementary data are available at Bioinformatics online.

    DOI: 10.1093/bioinformatics/btz313

    PubMed

    researchmap

  • Network-based characterization of drug-protein interaction signatures with a space-efficient approach. 国際誌

    Yasuo Tabei, Masaaki Kotera, Ryusuke Sawada, Yoshihiro Yamanishi

    BMC systems biology   13 ( Suppl 2 )   39 - 39   2019年4月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    BACKGROUND: Characterization of drug-protein interaction networks with biological features has recently become challenging in recent pharmaceutical science toward a better understanding of polypharmacology. RESULTS: We present a novel method for systematic analyses of the underlying features characteristic of drug-protein interaction networks, which we call "drug-protein interaction signatures" from the integration of large-scale heterogeneous data of drugs and proteins. We develop a new efficient algorithm for extracting informative drug-protein interaction signatures from the integration of large-scale heterogeneous data of drugs and proteins, which is made possible by space-efficient representations for fingerprints of drug-protein pairs and sparsity-induced classifiers. CONCLUSIONS: Our method infers a set of drug-protein interaction signatures consisting of the associations between drug chemical substructures, adverse drug reactions, protein domains, biological pathways, and pathway modules. We argue the these signatures are biologically meaningful and useful for predicting unknown drug-protein interactions and are expected to contribute to rational drug design.

    DOI: 10.1186/s12918-019-0691-1

    PubMed

    researchmap

  • Pathway-Based Drug Repositioning for Cancers: Computational Prediction and Experimental Validation. 国際誌

    Michio Iwata, Lisa Hirose, Hiroshi Kohara, Jiyuan Liao, Ryusuke Sawada, Sayaka Akiyoshi, Kenzaburo Tani, Yoshihiro Yamanishi

    Journal of medicinal chemistry   61 ( 21 )   9583 - 9595   2018年11月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Developing drugs with anticancer activity and low toxic side-effects at low costs is a challenging issue for cancer chemotherapy. In this work, we propose to use molecular pathways as the therapeutic targets and develop a novel computational approach for drug repositioning for cancer treatment. We analyzed chemically induced gene expression data of 1112 drugs on 66 human cell lines and searched for drugs that inactivate pathways involved in the growth of cancer cells (cell cycle) and activate pathways that contribute to the death of cancer cells (e.g., apoptosis and p53 signaling). Finally, we performed a large-scale prediction of potential anticancer effects for all the drugs and experimentally validated the prediction results via three in vitro cellular assays that evaluate cell viability, cytotoxicity, and apoptosis induction. Using this strategy, we successfully identified several potential anticancer drugs. The proposed pathway-based method has great potential to improve drug repositioning research for cancer treatment.

    DOI: 10.1021/acs.jmedchem.8b01044

    PubMed

    researchmap

  • KampoDB, database of predicted targets and functional annotations of natural medicines. 国際誌

    Ryusuke Sawada, Michio Iwata, Masahito Umezaki, Yoshihiko Usui, Toshikazu Kobayashi, Takaki Kubono, Shusaku Hayashi, Makoto Kadowaki, Yoshihiro Yamanishi

    Scientific reports   8 ( 1 )   11216 - 11216   2018年7月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Natural medicines (i.e., herbal medicines, traditional formulas) are useful for treatment of multifactorial and chronic diseases. Here, we present KampoDB ( http://wakanmoview.inm.u-toyama.ac.jp/kampo/ ), a novel platform for the analysis of natural medicines, which provides various useful scientific resources on Japanese traditional formulas Kampo medicines, constituent herbal drugs, constituent compounds, and target proteins of these constituent compounds. Potential target proteins of these constituent compounds were predicted by docking simulations and machine learning methods based on large-scale omics data (e.g., genome, proteome, metabolome, interactome). The current version of KampoDB contains 42 Kampo medicines, 54 crude drugs, 1230 constituent compounds, 460 known target proteins, and 1369 potential target proteins, and has functional annotations for biological pathways and molecular functions. KampoDB is useful for mode-of-action analysis of natural medicines and prediction of new indications for a wide range of diseases.

    DOI: 10.1038/s41598-018-29516-1

    PubMed

    researchmap

  • Predicting inhibitory and activatory drug targets by chemically and genetically perturbed transcriptome signatures. 国際誌

    Ryusuke Sawada, Michio Iwata, Yasuo Tabei, Haruka Yamato, Yoshihiro Yamanishi

    Scientific reports   8 ( 1 )   156 - 156   2018年1月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Genome-wide identification of all target proteins of drug candidate compounds is a challenging issue in drug discovery. Moreover, emerging phenotypic effects, including therapeutic and adverse effects, are heavily dependent on the inhibition or activation of target proteins. Here we propose a novel computational method for predicting inhibitory and activatory targets of drug candidate compounds. Specifically, we integrated chemically-induced and genetically-perturbed gene expression profiles in human cell lines, which avoided dependence on chemical structures of compounds or proteins. Predictive models for individual target proteins were simultaneously constructed by the joint learning algorithm based on transcriptomic changes in global patterns of gene expression profiles following chemical treatments, and following knock-down and over-expression of proteins. This method discriminates between inhibitory and activatory targets and enables accurate identification of therapeutic effects. Herein, we comprehensively predicted drug-target-disease association networks for 1,124 drugs, 829 target proteins, and 365 human diseases, and validated some of these predictions in vitro. The proposed method is expected to facilitate identification of new drug indications and potential adverse effects.

    DOI: 10.1038/s41598-017-18315-9

    PubMed

    researchmap

  • Biological meaning of "habitable zone" in nucleotide composition space.

    Shigeki Mitaku, Ryusuke Sawada

    Biophysics and physicobiology   15   75 - 85   2018年

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Organisms generally display two contrasting properties: large biodiversity and a uniform state of "life". In this study, we focused on the question of how genome sequences describe "life" where a large number of biomolecules are harmonized. We analyzed the whole genome sequence of 2664 organisms, paying attention to the nucleotide composition which is an intensive parameter from the genome sequence. The results showed that all organisms were plotted in narrow regions of the nucleotide composition space of the first and second letters of the codon. Since all genome sequences overlap irrespective of the living environment, it can be called a "habitable zone". The habitable zone deviates by 500 times the standard deviation from the nucleotide composition expected from the random sequence, indicating that unexpectedly rare sequences are realized. Furthermore, we found that the habitable zones at the first and second letters of the codon serve as the background mechanisms for the functional network of biological systems. The habitable zone at the second letter of the codon controls the formation of transmembrane regions and the habitable zone at the first letter controls the formation of molecular recognition unit. These analyses showed that the habitable zone of the nucleotide composition space and the exquisite arrangement of amino acids in the codon table are conjugated to form biological systems. Finally, we discussed the evolution of the higher order of genome sequences.

    DOI: 10.2142/biophysico.15.0_75

    PubMed

    researchmap

  • Elucidating the modes of action for bioactive compounds in a cell-specific manner by large-scale chemically-induced transcriptomics. 国際誌

    Michio Iwata, Ryusuke Sawada, Hiroaki Iwata, Masaaki Kotera, Yoshihiro Yamanishi

    Scientific reports   7   40164 - 40164   2017年1月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    The identification of the modes of action of bioactive compounds is a major challenge in chemical systems biology of diseases. Genome-wide expression profiling of transcriptional responses to compound treatment for human cell lines is a promising unbiased approach for the mode-of-action analysis. Here we developed a novel approach to elucidate the modes of action of bioactive compounds in a cell-specific manner using large-scale chemically-induced transcriptome data acquired from the Library of Integrated Network-based Cellular Signatures (LINCS), and analyzed 16,268 compounds and 68 human cell lines. First, we performed pathway enrichment analyses of regulated genes to reveal active pathways among 163 biological pathways. Next, we explored potential target proteins (including primary targets and off-targets) with cell-specific transcriptional similarity using chemical-protein interactome. Finally, we predicted new therapeutic indications for 461 diseases based on the target proteins. We showed the usefulness of the proposed approach in terms of prediction coverage, interpretation, and large-scale applicability, and validated the new prediction results experimentally by an in vitro cellular assay. The approach has a high potential for advancing drug discovery and repositioning.

    DOI: 10.1038/srep40164

    PubMed

    researchmap

  • What parameters characterize "life"?

    Shigeki Mitaku, Ryusuke Sawada

    Biophysics and physicobiology   13   305 - 310   2016年

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    "Life" is a particular state of matter, and matter is composed of various molecules. The state corresponding to "life" is ultimately determined by the genome sequence, and this sequence determines the conditions necessary for survival of the organism. In order to elucidate one parameter characterizing the state of "life", we analyzed the amino acid sequences encoded in the total genomes of 557 prokaryotes and 40 eukaryotes using a membrane protein prediction online tool called SOSUI. SOSUI uses only the physical parameters of the encoded amino acid sequences to make its predictions. The ratio of membrane proteins in a genome predicted by the SOSUI online tool was around 23% for all genomes, indicating that this parameter is controlled by some mechanism in cells. In order to identify the property of genome DNA sequences that is the possible cause of the constant ratio of membrane proteins, we analyzed the nucleotide compositions at codon positions and observed the existence of systematic biases distinct from those expected based on random distribution. We hypothesize that the constant ratio of membrane proteins is the result of random mutations restricted by the systematic biases inherent to nucleotide codon composition. A new approach to the biological sciences based on the holistic analysis of whole genomes is discussed in order to elucidate the principles underlying "life" at the biological system level.

    DOI: 10.2142/biophysico.13.0_305

    PubMed

    researchmap

  • Large-Scale Prediction of Beneficial Drug Combinations Using Drug Efficacy and Target Profiles. 国際誌

    Hiroaki Iwata, Ryusuke Sawada, Sayaka Mizutani, Masaaki Kotera, Yoshihiro Yamanishi

    Journal of chemical information and modeling   55 ( 12 )   2705 - 16   2015年12月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    The identification of beneficial drug combinations is a challenging issue in pharmaceutical and clinical research toward combinatorial drug therapy. In the present study, we developed a novel computational method for large-scale prediction of beneficial drug combinations using drug efficacy and target profiles. We designed an informative descriptor for each drug-drug pair based on multiple drug profiles representing drug-targeted proteins and Anatomical Therapeutic Chemical Classification System codes. Then, we constructed a predictive model by learning a sparsity-induced classifier based on known drug combinations from the Orange Book and KEGG DRUG databases. Our results show that the proposed method outperforms the previous methods in terms of the accuracy of high-confidence predictions, and the extracted features are biologically meaningful. Finally, we performed a comprehensive prediction of novel drug combinations for 2,639 approved drugs, which predicted 142,988 new potentially beneficial drug-drug pairs. We showed several examples of successfully predicted drug combinations for a variety of diseases.

    DOI: 10.1021/acs.jcim.5b00444

    PubMed

    researchmap

  • Target-Based Drug Repositioning Using Large-Scale Chemical-Protein Interactome Data. 国際誌

    Ryusuke Sawada, Hiroaki Iwata, Sayaka Mizutani, Yoshihiro Yamanishi

    Journal of chemical information and modeling   55 ( 12 )   2717 - 30   2015年12月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Drug repositioning, or the identification of new indications for known drugs, is a useful strategy for drug discovery. In this study, we developed novel computational methods to predict potential drug targets and new drug indications for systematic drug repositioning using large-scale chemical-protein interactome data. We explored the target space of drugs (including primary targets and off-targets) based on chemical structure similarity and phenotypic effect similarity by making optimal use of millions of compound-protein interactions. On the basis of the target profiles of drugs, we constructed statistical models to predict new drug indications for a wide range of diseases with various molecular features. The proposed method outperformed previous methods in terms of interpretability, applicability, and accuracy. Finally, we conducted a comprehensive prediction of the drug-target-disease association network for 8270 drugs and 1401 diseases and showed biologically meaningful examples of newly predicted drug targets and drug indications. The predictive model is useful to understand the mechanisms of the predicted drug indications.

    DOI: 10.1021/acs.jcim.5b00330

    PubMed

    researchmap

  • Predicting target proteins for drug candidate compounds based on drug-induced gene expression data in a chemical structure-independent manner. 国際誌

    Yoshiyuki Hizukuri, Ryusuke Sawada, Yoshihiro Yamanishi

    BMC medical genomics   8   82 - 82   2015年12月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    BACKGROUND: Phenotype-based high-throughput screening is a useful technique for identifying drug candidate compounds that have a desired phenotype. However, the molecular mechanisms of the hit compounds remain unknown, and substantial effort is required to identify the target proteins associated with the phenotype. METHODS: In this study, we propose a new method to predict target proteins of drug candidate compounds based on drug-induced gene expression data in Connectivity Map and a machine learning classification technique, which we call the "transcriptomic approach." RESULTS: Unlike existing methods such as the chemogenomic approach, the transcriptomic approach enabled the prediction of target proteins without dependence on prior knowledge of compound chemical structures. The prediction accuracy of the chemogenomic approach was highly depended on compounds structure similarities in data sets. In contrast, the prediction accuracy of the transcriptomic approach was maintained at a sufficient level, even for benchmark data consisting of structurally diverse compounds. CONCLUSIONS: The transcriptomic approach reported here is expected to be a useful tool for structure-independent prediction of target proteins for drug candidate compounds.

    DOI: 10.1186/s12920-015-0158-1

    PubMed

    researchmap

  • Systematic drug repositioning for a wide range of diseases with integrative analyses of phenotypic and molecular data. 国際誌

    Hiroaki Iwata, Ryusuke Sawada, Sayaka Mizutani, Yoshihiro Yamanishi

    Journal of chemical information and modeling   55 ( 2 )   446 - 59   2015年2月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Drug repositioning, or the application of known drugs to new indications, is a challenging issue in pharmaceutical science. In this study, we developed a new computational method to predict unknown drug indications for systematic drug repositioning in a framework of supervised network inference. We defined a descriptor for each drug-disease pair based on the phenotypic features of drugs (e.g., medicinal effects and side effects) and various molecular features of diseases (e.g., disease-causing genes, diagnostic markers, disease-related pathways, and environmental factors) and constructed a statistical model to predict new drug-disease associations for a wide range of diseases in the International Classification of Diseases. Our results show that the proposed method outperforms previous methods in terms of accuracy and applicability, and its performance does not depend on drug chemical structure similarity. Finally, we performed a comprehensive prediction of a drug-disease association network consisting of 2349 drugs and 858 diseases and described biologically meaningful examples of newly predicted drug indications for several types of cancers and nonhereditary diseases.

    DOI: 10.1021/ci500670q

    PubMed

    researchmap

  • Benchmarking a Wide Range of Chemical Descriptors for Drug-Target Interaction Prediction Using a Chemogenomic Approach. 国際誌

    Ryusuke Sawada, Masaaki Kotera, Yoshihiro Yamanishi

    Molecular informatics   33 ( 11-12 )   719 - 31   2014年12月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    The identification of drug-target interactions, or interactions between drug candidate compounds and target candidate proteins, is a crucial process in genomic drug discovery. In silico chemogenomic methods are recently recognized as a promising approach for genome-wide scale prediction of drug-target interactions, but the prediction performance depends heavily on the descriptors and similarity measures of drugs and proteins. In this paper, we investigated the performance of various descriptors and similarity measures of drugs and proteins for the drug-target interaction prediction using a chemogenomic approach. We compared the prediction accuracy of 18 chemical descriptors of drugs (e.g., ECFP, FCFP,E-state, CDK, KlekotaRoth, MACCS, PubChem, Dragon, KCF-S, and graph kernels) and 4 descriptors of proteins (e.g., amino acid composition, domain profile, local sequence similarity, and string kernel) on about one hundred thousand drug-target interactions. We examined the combinatorial effects of drug descriptors and protein descriptors using the same benchmark data under several experimental conditions. Large-scale experiments showed that our proposed KCF-S descriptor worked the best in terms of prediction accuracy. The comparative results are expected to be useful for selecting chemical descriptors in various pharmaceutical applications.

    DOI: 10.1002/minf.201400066

    PubMed

    researchmap

  • DINIES: drug-target interaction network inference engine based on supervised analysis. 国際誌

    Yoshihiro Yamanishi, Masaaki Kotera, Yuki Moriya, Ryusuke Sawada, Minoru Kanehisa, Susumu Goto

    Nucleic acids research   42 ( Web Server issue )   W39-45   2014年7月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    DINIES (drug-target interaction network inference engine based on supervised analysis) is a web server for predicting unknown drug-target interaction networks from various types of biological data (e.g. chemical structures, drug side effects, amino acid sequences and protein domains) in the framework of supervised network inference. The originality of DINIES lies in prediction with state-of-the-art machine learning methods, in the integration of heterogeneous biological data and in compatibility with the KEGG database. The DINIES server accepts any 'profiles' or precalculated similarity matrices (or 'kernels') of drugs and target proteins in tab-delimited file format. When a training data set is submitted to learn a predictive model, users can select either known interaction information in the KEGG DRUG database or their own interaction data. The user can also select an algorithm for supervised network inference, select various parameters in the method and specify weights for heterogeneous data integration. The server can provide integrative analyses with useful components in KEGG, such as biological pathways, functional hierarchy and human diseases. DINIES (http://www.genome.jp/tools/dinies/) is publicly available as one of the genome analysis tools in GenomeNet.

    DOI: 10.1093/nar/gku337

    PubMed

    researchmap

  • Biological meaning of DNA compositional biases evaluated by ratio of membrane proteins. 国際誌

    Ryusuke Sawada, Shigeki Mitaku

    Journal of biochemistry   151 ( 2 )   189 - 96   2012年2月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Membrane spanning regions can be used as markers for studying the robustness of biologically important units of proteins against evolutionary change (R. Sawada and S. Mitaku, Genes to Cells, 2010). We carried out computational experiments of extensive DNA mutations on the assumption of constant GC content or constant codon positional nucleotide biases. Randomized sequences were evaluated by membrane protein prediction systems SOSUI and SOSUIsignal. When all amino acid sequences from the total real genomes of 538 prokaryotes were analysed, ratios of membrane proteins to all genes in the total genomes were almost constant around a ratio of 22% with a standard deviation of 1.56. When the nucleotide sequences were randomized, keeping only the GC contents constant, the ratios of membrane proteins became highly diverse with a standard deviation of 10.1. When the codon positional nucleotide biases were taken into account; however, the diverse ratios of membrane proteins converged to a value of ~25% with a standard deviation of 3.55. These results suggest that codon compositional biases play an important role in the evolution of prokaryotes for maintaining a constant ratio of membrane proteins. Further detailed analysis suggested that non-uniform nucleotide compositional biases at the terminal regions are the reason for the small but significant deviation.

    DOI: 10.1093/jb/mvr132

    PubMed

    researchmap

  • How are exons encoding transmembrane sequences distributed in the exon-intron structure of genes? 国際誌

    Ryusuke Sawada, Shigeki Mitaku

    Genes to cells : devoted to molecular & cellular mechanisms   16 ( 1 )   115 - 21   2011年1月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    The exon-intron structure of eukaryotic genes raises a question about the distribution of transmembrane regions in membrane proteins. Were exons that encode transmembrane regions formed simply by inserting introns into preexisting genes or by some kind of exon shuffling? To answer this question, the exon-per-gene distribution was analyzed for all genes in 40 eukaryotic genomes with a particular focus on exons encoding transmembrane segments. In 21 higher multicellular eukaryotes, the percentage of multi-exon genes (those containing at least one intron) within all genes in a genome was high (>70%) and with a mean of 87%. When genes were grouped by the number of exons per gene in higher eukaryotes, good exponential distributions were obtained not only for all genes but also for the exons encoding transmembrane segments, leading to a constant ratio of membrane proteins independent of the exon-per-gene number. The positional distribution of transmembrane regions in single-pass membrane proteins showed that they are generally located in the amino or carboxyl terminal regions. This nonrandom distribution of transmembrane regions explains the constant ratio of membrane proteins to the exon-per-gene numbers because there are always two terminal (i.e., the amino and carboxyl) regions - independent of the length of sequences.

    DOI: 10.1111/j.1365-2443.2010.01468.x

    PubMed

    researchmap

  • Vertebrate genomes code excess proteins with charge periodicity of 28 residues. 国際誌

    Runcong Ke, Noriyuki Sakiyama, Ryusuke Sawada, Masashi Sonoyama, Shigeki Mitaku

    Journal of biochemistry   143 ( 5 )   661 - 5   2008年5月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    All amino acid sequences derived from 248 prokaryotic genomes, 10 invertebrate genomes (plants and fungi) and 10 vertebrate genomes were analysed by the autocorrelation function of charge sequences. The analysis of the total amino acid sequences derived from the 268 biological genomes showed that a significant periodicity of 28 residues is observable for the vertebrate genomes, but not for the other genomes. When proteins with a charge periodicity of 28 residues (PCP28) were selected from the total proteomes, we found that PCP28 in fact exists in all proteomes, but the number of PCP28 is much larger for the vertebrate proteomes than for the other proteomes. Although excess PCP28 in the vertebrate proteomes are only poorly characterized, a detailed inspection of the databases suggests that most excess PCP28 are nuclear proteins.

    DOI: 10.1093/jb/mvn017

    PubMed

    researchmap

  • Nuclear proteins with charge periodicity of 28 residues are specifically increased in vertebrate genomes 査読

    崎山 則征, 柯 閏聡, 澤田 隆介, 園山 正史, 美宅 成樹

    Chem-Bio Informatics Journal   7 ( 3 )   69 - 78   2007年

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:Chem-Bio Informatics Society  

    ヒトの全タンパク質において電荷の自己相関関数の計算から、電荷の28残基周期性を持つタンパク質(PCP28)が最近発見された(Ke et al., Jpn. J. Appl. Phys. 2007)。PCP28の主な局在位置は核であった。核PCP28の生物学的意味を考察するために、我々が開発した予測システム(Sakiyama et al., CBIJ., 2007)を用いて、10種類の脊椎動物ゲノムと7種類の非脊椎真核生物から核PCP28を予測した。Swiss-Protデータベースによるとヒトの核PCP28の約90%は転写制御因子と考えられた。次に、脊椎動物ゲノムと非脊椎真核生物ゲノムに含まれる核PCP28の数を比較した。その結果、核PCP28は脊椎動物ゲノムにおいて顕著な増加を示すことが明らかになった。また、核以外のPCP28の割合は全ての真核生物でほぼ一定であった。これは、核PCP28が脊椎動物に特有のタンパク質である可能性を強く示唆している。

    DOI: 10.1273/cbij.7.69

    CiNii Article

    researchmap

  • Ratio of membrane proteins in total proteomes of prokaryota.

    Ryusuke Sawada, Runcong Ke, Toshiyuki Tsuji, Masashi Sonoyama, Shigeki Mitaku

    Biophysics (Nagoya-shi, Japan)   3   37 - 45   2007年

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    The numbers of membrane proteins in the current genomes of various organisms provide an important clue about how the protein world has evolved from the aspect of membrane proteins. Numbers of membrane proteins were estimated by analyzing the total proteomes of 248 prokaryota, using the SOSUI system for membrane proteins (Hirokawa et al., Bioinformatics, 1998) and SOSUI-signal for signal peptides (Gomi et al., CBIJ, 2004). The results showed that the ratio of membrane proteins to total proteins in these proteomes was almost constant: 0.228. When amino acid sequences were randomized, setting the probability of occurrence of all amino acids to 5%, the membrane protein/total protein ratio decreased to about 0.085. However, when the same simulation was carried out, but using the amino acid composition of the above proteomes, this ratio was 0.218, which is nearly the same as that of the real proteomic systems. This fact is consistent with the birth, death and innovation (BDI) model for membrane proteins, in which transmembrane segments emerge and disappear in accordance with random mutation events.

    PubMed

    researchmap

  • Comparative proteomics of the prokaryota using secretory proteins 査読

    五味 雅裕, 澤田 隆介, 園山 正史, 美宅 成樹

    Chem-Bio Informatics Journal   5 ( 3 )   56 - 64   2006年2月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:Chem-Bio Informatics Society  

    分泌タンパク質は細胞間のやり取りを橋渡しする役目を持っており、生物種の生存戦略と密接な関わりがある。膜タンパク質予測システムSOSUIとシグナルペプチド予測システムSOSUIsignalを用いて248種の原核生物ゲノムから分泌タンパク質の予測を行った。分泌タンパク質の数とゲノムのORF数には正の相関がみられた。詳細な解析より、原核生物をいくつかのグループに分けることができた。ORF数が1200以下の生物は真核生物細胞内共生、寄生生物で、一つの線形近似が可能だった。2500以上の生物種は独立的に生存できる生物であり、3つのカテゴリに分けられた。線形近似のX軸切片は共生-寄生生物種では300、独立生存グループでは700であった。また、GC含量もORF数と同様に、生物のカテゴリを分ける主な要因であった。最後に原核生物の生存戦略を分泌タンパク質の解析に基いて議論した

    DOI: 10.1273/cbij.5.56

    CiNii Article

    researchmap

▼全件表示

MISC

  • 機械学習による食品の機能性の網羅的な予測と作用機序の解明

    柴田友和, 田中由祐, 田口大夢, 澤田隆介, 青柳守紘, 平尾宜司, 山西芳裕

    日本薬学会年会要旨集(Web)   142nd   2022年

     詳細を見る

  • 生薬比率を考慮した漢方薬の作用機序や効能のin silico予測

    島田祐樹, 江副晃洋, 澤田隆介, 柴田友和, 門脇真, 山西芳裕

    和漢医薬学会学術大会要旨集   39th   2022年

     詳細を見る

  • AlphaFold2より得られたヒト全タンパク質立体構造との結合親和性に基づく医薬品化合物の副作用予測

    澤田隆介, 柴田友和, 坂尻由子, 山西芳裕

    日本薬学会年会要旨集(Web)   142nd   2022年

     詳細を見る

  • AlphaFold2から得られたヒト全タンパク質立体構造への結合親和性を考慮したドラッグリポジショニング

    坂尻由子, 柴田友和, 澤田隆介, 山西芳裕

    日本薬学会年会要旨集(Web)   142nd   2022年

     詳細を見る

  • 遺伝性脊髄小脳変性症にトピラマートは有効か?

    三浦 史郎, 澤田 隆介, 貴田 浩志, 頼田 章子, 鎌田 崇嗣, 山西 芳裕

    臨床神経学   60 ( Suppl. )   S433 - S433   2020年11月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • インシリコスクリーニングによる新規CFTRコレクターの探索

    谷口正伍, 福田亮介, BERENGER Francois, 澤田隆介, 山口美穂, 井上敬太郎, 青木俊介, 山西芳裕, 沖米田司

    日本薬学会年会要旨集(Web)   140th   2020年

     詳細を見る

  • Tensor‐train分解アルゴリズムによる高次テンソルデータ解析:薬物応答遺伝子発現データへの応用

    岩田通夫, YUAN Longhao, ZHAO Qibin, 田部井靖生, BERENGER Francois, 澤田隆介, 秋好紗弥香, 山西芳裕, 山西芳裕

    日本計算機統計学会大会論文集   32nd ( 0 )   76‐77 - 77   2018年5月

     詳細を見る

    記述言語:日本語   出版者・発行元:日本計算機統計学会  

    DOI: 10.20551/jscstaikai.32.0_76

    CiNii Article

    J-GLOBAL

    researchmap

  • 漢方薬リポジショニング:ビッグデータと機械学習による漢方薬の効能予測

    澤田隆介, 岩田通夫, 梅崎雅人, 臼井義比古, 小林敏一, 窪野孝貴, 林周作, 門脇真, 山西芳裕, 山西芳裕

    ケモインフォマティクス討論会予稿集(Web)   41st   2018年

     詳細を見る

  • 異種オミックスデータに基づく医薬品候補化合物の標的分子や効能の予測

    澤田隆介, 山西芳裕

    CBI学会大会   2017   2017年

     詳細を見る

  • 薬物の標的タンパク質プロファイルとオミックス情報に基づくドラッグリポジショニング

    澤田隆介, 岩田浩明, 山西芳裕, 山西芳裕

    日本生化学会大会(Web)   88th   2015年

     詳細を見る

  • 化合物応答遺伝子発現プロファイルの大規模解析による生理活性化合物の作用機序推定と創薬への応用

    岩田通夫, 澤田隆介, 岩田浩明, 山西芳裕, 山西芳裕

    日本生化学会大会(Web)   88th   2015年

     詳細を見る

  • Nuclear localization of proteins with a charge periodicity of 28 residues

    Noriyuki Sakiyama, Runcong Ke, Ryuusuke Sawada, Masashi Sonoyama, Shigeki Mitaku

    Chem-Bio Informatics Journal   7 ( 2 )   35 - 48   2008年1月

     詳細を見る

    記述言語:英語  

    Proteins with a charge periodicity of 28 residues (PCP28) were found recently in the human proteome, and many of the annotated PCP28 were located in the nucleus (Ke et al., Jpn. J. Appl. Phys. 2007). The physical properties of the amino acid sequences were analyzed to detect the difference in the physicochemistry between the nuclear and cytoplasmic PCP28 and develop a software system to classify the two types of PCP28. A significant difference in the global parameters from the entire sequence and the local parameters around a segment with the highest positive charge density was found between the nuclear and cytoplasmic PCP28. The global classification score included the densities of proline and cysteine, and the negative charge density, while the local score included the symmetry.of the charge distribution, the density of cysteine, and the positive charge density. A prediction system was developed using the global and local scores, which possessed a sensitivity and specificity of 92% and 88%, respectively. The mechanism of translocation of proteins to the nucleus is discussed using the parameters relevant to the predictive system. Copyright 2007 Chem-Bio Informatics Society.

    DOI: 10.1273/cbij.7.35

    Scopus

    researchmap

  • Human genome encodes many proteins with charge periodicity of 28 residues

    Runcong Ke, Noriyuki Sakiyama, Ryusuke Sawada, Masashi Sonoyama, Shigeki Mitaku

    JAPANESE JOURNAL OF APPLIED PHYSICS PART 1-REGULAR PAPERS BRIEF COMMUNICATIONS & REVIEW PAPERS   46 ( 9A )   6083 - 6086   2007年9月

     詳細を見る

    記述言語:英語   出版者・発行元:JAPAN SOC APPLIED PHYSICS  

    The human genome includes more than 36,000 open reading frames that are translated to amino acid sequences of proteins. When the charge distribution in amino acid sequences from the total human genome was analyzed by the autocorrelation function, a surprisingly sharp periodicity of 28 residues was observed. Every protein with the charge periodicity of 28 residues (PCP28) could be discriminated by a simple algorithm, and the number of PCP28 amounted to about 3% of the total open reading frames of the human genome. The net charge of most PCP28 was highly positive. The possible structural and functional features of this type of protein were discussed in terms of the electric repulsion within molecules.

    DOI: 10.1143/JJAP.46.6083

    Web of Science

    CiNii Article

    researchmap

▼全件表示

 

担当授業科目

  • 薬理学 (2023年度) 特別  - その他

  • 薬理学実習 (2023年度) 特別  - その他

  • 薬理学 (2022年度) 特別  - その他

  • 薬理学実習 (2022年度) 特別  - その他